# Astellas Pharma Inc. – FDA Inspection, Mar 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a24c61dd-8240-493f-bad1-7c0abd0c4f4c
Source feed: FDA_Inspections

> FDA inspection 1081668 of Astellas Pharma Inc., March 05, 2019. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081668
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2019-03-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1274944 - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/dd27836e-06a5-4845-980e-a356aeaafacc)
- FDA Inspection 963371 - 2016-03-18
- [FDA Inspection 874760 - 2014-04-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/f2164931-62b5-469c-a796-70010506df65)
- FDA Inspection 756552 - 2011-11-21
- [FDA Inspection 548559 - 2008-11-07](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/f2647247-4f2e-4543-b111-52cad2d1e7e2)

## Related Officers

- [Jose A. Cruz Gonzalez](https://www.keypedia.com/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374)

Company: https://www.keypedia.com/companies/astellas-pharma-inc/ad5c1a7d-23cf-412a-88ce-62ab257c3233

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c